RHUMBLINE ADVISERS - MERIDIAN BIOSCIENCE INC ownership

MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 189 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2021. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of MERIDIAN BIOSCIENCE INC
ValueSharesWeighting
Q4 2022$3,221
-99.9%
96,989
+2.0%
0.00%0.0%
Q3 2022$2,997,000
-13.9%
95,060
-16.9%
0.00%
-20.0%
Q2 2022$3,480,000
+11.1%
114,407
-5.2%
0.01%
+25.0%
Q1 2022$3,132,000
+21.5%
120,651
-4.5%
0.00%
+33.3%
Q4 2021$2,578,000
+7.5%
126,390
+1.4%
0.00%0.0%
Q3 2021$2,398,000
-22.9%
124,612
-11.2%
0.00%
-25.0%
Q2 2021$3,112,000
-10.3%
140,312
+6.2%
0.00%
-20.0%
Q1 2021$3,469,000
+41.6%
132,140
+0.9%
0.01%
+66.7%
Q4 2020$2,449,000
+14.7%
131,009
+4.2%
0.00%0.0%
Q3 2020$2,135,000
-31.9%
125,736
-6.5%
0.00%
-40.0%
Q2 2020$3,133,000
+146.7%
134,518
-11.1%
0.01%
+66.7%
Q1 2020$1,270,000
-11.2%
151,240
+3.3%
0.00%
+50.0%
Q4 2019$1,430,000
+7.6%
146,338
+4.5%
0.00%0.0%
Q3 2019$1,329,000
-15.7%
140,047
+5.6%
0.00%
-33.3%
Q2 2019$1,576,000
-27.0%
132,666
+8.2%
0.00%
-25.0%
Q1 2019$2,159,000
+1.7%
122,599
+0.3%
0.00%
-20.0%
Q4 2018$2,123,000
+41.1%
122,287
+21.1%
0.01%
+66.7%
Q3 2018$1,505,000
-9.2%
100,998
-3.1%
0.00%0.0%
Q2 2018$1,657,000
+14.8%
104,204
+2.5%
0.00%0.0%
Q1 2018$1,444,000
+4.6%
101,684
+3.2%
0.00%0.0%
Q4 2017$1,380,000
+13.5%
98,554
+15.9%
0.00%0.0%
Q3 2017$1,216,000
-46.0%
85,063
-40.5%
0.00%
-40.0%
Q2 2017$2,252,000
+12.7%
142,969
-1.3%
0.01%0.0%
Q1 2017$1,998,000
-5.8%
144,796
+20.8%
0.01%0.0%
Q4 2016$2,122,000
-7.6%
119,880
+0.7%
0.01%
-16.7%
Q3 2016$2,297,000
-3.6%
119,069
-2.6%
0.01%
-14.3%
Q2 2016$2,383,000
-4.7%
122,224
+0.8%
0.01%
-12.5%
Q1 2016$2,500,000
+3.5%
121,284
+3.1%
0.01%0.0%
Q4 2015$2,415,000
+25.3%
117,674
+4.4%
0.01%
+14.3%
Q3 2015$1,928,000
-12.0%
112,749
-4.0%
0.01%0.0%
Q2 2015$2,190,000
-5.7%
117,505
-3.5%
0.01%0.0%
Q1 2015$2,323,000
+44.6%
121,730
+24.7%
0.01%
+40.0%
Q4 2014$1,607,000
-11.1%
97,630
-4.4%
0.01%0.0%
Q3 2014$1,807,000
-8.7%
102,140
+6.5%
0.01%
-16.7%
Q2 2014$1,980,000
-9.4%
95,930
-4.4%
0.01%0.0%
Q1 2014$2,186,000
-25.6%
100,340
-9.4%
0.01%
-33.3%
Q4 2013$2,937,000
+12.9%
110,710
+0.7%
0.01%
+12.5%
Q3 2013$2,601,000
+20.1%
109,970
+9.2%
0.01%
+14.3%
Q2 2013$2,165,000100,7030.01%
Other shareholders
MERIDIAN BIOSCIENCE INC shareholders Q2 2021
NameSharesValueWeighting ↓
SYQUANT CAPITAL SAS 134,804$4,47711.01%
Vazirani Asset Management LLC 115,774$3,8456.51%
FIFTH LANE CAPITAL, LP 185,914$6,174,2045.56%
NEXPOINT ASSET MANAGEMENT, L.P. 1,939,075$64,396,6815.01%
Crystalline Management Inc. 244,453$8,118,2844.08%
FNY Investment Advisers, LLC 51,000$1,6932.36%
HAVENS ADVISORS LLC 26,800$890,0282.26%
Euclidean Technologies Management, LLC 62,995$2,092,0641.99%
Sand Grove Capital Management LLP 537,060$17,8361.70%
Crabel Capital Management, LLC 120,337$3,9961.45%
View complete list of MERIDIAN BIOSCIENCE INC shareholders